ATE509921T1 - Substituierte carbonsäureamide als antagonisten des gruppe-i-metabotropen rezeptors - Google Patents

Substituierte carbonsäureamide als antagonisten des gruppe-i-metabotropen rezeptors

Info

Publication number
ATE509921T1
ATE509921T1 AT07873705T AT07873705T ATE509921T1 AT E509921 T1 ATE509921 T1 AT E509921T1 AT 07873705 T AT07873705 T AT 07873705T AT 07873705 T AT07873705 T AT 07873705T AT E509921 T1 ATE509921 T1 AT E509921T1
Authority
AT
Austria
Prior art keywords
antagonists
group
substituted carboxylic
carboxylic amides
metabotropic receptor
Prior art date
Application number
AT07873705T
Other languages
English (en)
Inventor
Ryan Backer
Matthew Fisher
Steven Kuklish
Sean Hollinshead
Edward Smith
Kumiko Takeuchi
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE509921T1 publication Critical patent/ATE509921T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07873705T 2006-06-08 2007-06-07 Substituierte carbonsäureamide als antagonisten des gruppe-i-metabotropen rezeptors ATE509921T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81183906P 2006-06-08 2006-06-08
PCT/US2007/070572 WO2008103185A2 (en) 2006-06-08 2007-06-07 Substituted carboxamides as group i metabotropic receptor antagonists

Publications (1)

Publication Number Publication Date
ATE509921T1 true ATE509921T1 (de) 2011-06-15

Family

ID=39673278

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07873705T ATE509921T1 (de) 2006-06-08 2007-06-07 Substituierte carbonsäureamide als antagonisten des gruppe-i-metabotropen rezeptors

Country Status (30)

Country Link
US (1) US7960419B2 (de)
EP (1) EP2076502B1 (de)
JP (1) JP5108878B2 (de)
KR (1) KR101051559B1 (de)
CN (1) CN101466691B (de)
AT (1) ATE509921T1 (de)
AU (1) AU2007347428B2 (de)
BR (1) BRPI0712862A2 (de)
CA (1) CA2652074C (de)
CR (1) CR10410A (de)
CY (1) CY1111588T1 (de)
DK (1) DK2076502T3 (de)
EA (1) EA014233B1 (de)
EC (1) ECSP088939A (de)
ES (1) ES2362949T3 (de)
HR (1) HRP20110436T1 (de)
IL (1) IL195632A (de)
MA (1) MA30620B1 (de)
MX (1) MX2008015485A (de)
MY (1) MY148084A (de)
NO (1) NO341474B1 (de)
NZ (1) NZ573352A (de)
PL (1) PL2076502T3 (de)
PT (1) PT2076502E (de)
RS (1) RS51818B (de)
SI (1) SI2076502T1 (de)
TN (1) TNSN08506A1 (de)
UA (1) UA95480C2 (de)
WO (1) WO2008103185A2 (de)
ZA (1) ZA200809111B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0804685D0 (en) 2008-03-13 2008-04-16 Univ Edinburgh Therapeutic compounds and their use
CA2720631C (en) 2008-04-04 2012-08-28 Eli Lilly And Company 3-indazolyl-4-pyridylisothiazoles
EP2443113A1 (de) * 2009-06-15 2012-04-25 The University Of Edinburgh Amidoisothiazolverbindungen und ihre verwendung als 11beta-hsd1-hemmer zur behandlung von stoffwechselsyndrom und assoziierten erkrankungen
EP2477983B1 (de) 2009-09-16 2015-04-15 The University Of Edinburgh (4-phenyl-piperidin-1-yl)-[5-1h-pyrazol-4yl)-thiophen-3-yl]-methanon-verbindungen und deren verwendung
WO2011135276A1 (en) 2010-04-29 2011-11-03 The University Of Edinburgh 3, 3 -disubstituted- ( 8 - aza - bicyclo [3.2.1] oct- 8 - yl) -[5- (1h - pyrazol - 4 -yl) -thiophen-3 -yl] methanones as inhibitors of 11 (beta) -hsd1
ES2641469T3 (es) 2012-11-13 2017-11-10 Nissan Chemical Industries, Ltd. Compuesto de 2-piridona
WO2018054846A1 (de) 2016-09-23 2018-03-29 Bayer Aktiengesellschaft N3-cyclisch substituierte thienouracile und ihre verwendung
CN117567266B (zh) * 2023-11-07 2024-06-14 康龙化成手性医药技术(宁波)有限公司 一种制备2-甲基环丙羧酸的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL72091A0 (en) * 1983-06-20 1984-10-31 Lilly Co Eli N'-substituted(3-aryl 5-isothiazolyl)urea derivatives
DE4328425A1 (de) * 1993-08-24 1995-03-02 Basf Ag Acylamino-substituierte Isoxazol- bzw. Isothiazolderivate, Verfahren zu deren Herstellung und ihre Verwendung
DK124393D0 (da) * 1993-11-03 1993-11-03 Lundbeck & Co As H Compounds
DE19542372A1 (de) * 1995-11-14 1997-05-15 Bayer Ag Acylierte 5-Aminoisothiazole
UA60365C2 (uk) * 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
JP3411262B2 (ja) * 1999-08-20 2003-05-26 萬有製薬株式会社 新規スピロ化合物
EP1435948A1 (de) * 2001-08-06 2004-07-14 Pharmacia Italia S.p.A. Aminoisoxazol-derivate mit wirkung als kinasehemmer
WO2005030128A2 (en) * 2003-09-23 2005-04-07 Merck & Co., Inc. Pyrazole modulators of metabotropic glutamate receptors
WO2005113534A2 (en) * 2004-05-12 2005-12-01 Schering Corporation Cxcr1 and cxcr2 chemokine antagonists
JP2008513434A (ja) * 2004-09-23 2008-05-01 ファイザー・プロダクツ・インク トロンボポイエチン受容体アゴニスト

Also Published As

Publication number Publication date
UA95480C2 (uk) 2011-08-10
SI2076502T1 (sl) 2011-09-30
CA2652074C (en) 2013-08-06
EP2076502B1 (de) 2011-05-18
IL195632A (en) 2013-11-28
IL195632A0 (en) 2009-09-01
NO341474B1 (no) 2017-11-27
JP2009539874A (ja) 2009-11-19
KR20090008460A (ko) 2009-01-21
MX2008015485A (es) 2009-03-06
CA2652074A1 (en) 2008-08-28
CN101466691B (zh) 2011-07-27
WO2008103185A2 (en) 2008-08-28
PT2076502E (pt) 2011-06-07
MY148084A (en) 2013-02-28
HK1131984A1 (en) 2010-02-12
BRPI0712862A2 (pt) 2012-12-18
PL2076502T3 (pl) 2011-09-30
ZA200809111B (en) 2009-12-30
TNSN08506A1 (en) 2010-04-14
HRP20110436T1 (hr) 2011-08-31
NO20085028L (no) 2008-12-02
MA30620B1 (fr) 2009-08-03
US7960419B2 (en) 2011-06-14
CN101466691A (zh) 2009-06-24
EP2076502A2 (de) 2009-07-08
RS51818B (sr) 2011-12-31
EA200870516A1 (ru) 2009-06-30
NZ573352A (en) 2011-10-28
DK2076502T3 (da) 2011-07-25
JP5108878B2 (ja) 2012-12-26
AU2007347428A1 (en) 2008-08-28
CR10410A (es) 2008-11-28
ES2362949T3 (es) 2011-07-15
KR101051559B1 (ko) 2011-07-22
CY1111588T1 (el) 2015-10-07
AU2007347428B2 (en) 2012-02-09
US20090182025A1 (en) 2009-07-16
WO2008103185A3 (en) 2008-10-30
ECSP088939A (es) 2009-01-30
EA014233B1 (ru) 2010-10-29

Similar Documents

Publication Publication Date Title
ATE509921T1 (de) Substituierte carbonsäureamide als antagonisten des gruppe-i-metabotropen rezeptors
IL184932A0 (en) Glucagon receptor antagonists, preperation and therapeutic uses
DE602007010781D1 (de) N- (phenylmethyl) -2- (1h-pyrazol-4-yl) acetamid-derivate als p2x7-antagonisten zur behandlung von schmerzen, entzündungen und neurodegeneration
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
DE602008004265D1 (de) Trans-3-aza-bicyclo-ä3.1.0ü-hexan-derivate
ATE484505T1 (de) 5-sulfanylmethylä1,2,4ütriazolä1,5-aüpyrimidin- - olderivate als cxcr2-antagonisten
UA92670C2 (ru) Пиразолиновые соединения и их фармацевтическое применение, композиция на их основе
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
MA28706B1 (fr) Antagoniste des recepteurs du glucagon, preparation et utilisations therapeutiques
NO20090779L (no) 5,6-bisaryl-2-pyridin-karboksamidderivater, fremstilling og anvendelse derav i terapeutika som uretosin II receptorantagonister
EA201300436A8 (ru) Совместные кристаллы и соли ингибиторов ccr3
CY1109694T1 (el) Παραγωγα πυρρολιδινης ως ανταγωνιστες υποδοχεα η3 ισταμινης
ATE466842T1 (de) 3-substituierte pyridinderivate als h3- antagonisten
UA107702C2 (xx) Похідні бензаміду
ATE482195T1 (de) Benzoäfüisoindole als antagonisten des ep4- rezeptors
SI1805169T1 (sl) Inhibitorji histamin h3 receptorja, njihova priprava in terapevtske uporabe
DOP2008000064A (es) Carboxamidas sustituidas.
TN2011000508A1 (en) Substituted piperidines as ccr3 antagonists

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2076502

Country of ref document: EP